Inventor

LAGU BHARAT

US45 patents

⚠️ This page may combine multiple inventors who share the name “LAGU BHARAT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LAGU BHARAT

MITOBRIDGE INC

HMOX1 inducers

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

Poly-ADP ribose polymerase (PARP) inhibitors

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

Crystalline and salt forms of PPAR agonist compounds

Crystalline and salt forms of PPAR agonist compounds

Poly-ADP ribose polymerase (PARP) inhibitors

Crystalline and salt forms of PPAR agonist compounds

USP30 inhibitors

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof

SYNAPTIC PHARMA CORP

Oxazolidinones and uses thereof

Oxazolidinones as α1A receptor antagonists

5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines

5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines

Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof

5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines

Morpholinone and morpholine derivatives and uses thereof

Morpholinone and morpholine derivatives and uses thereof

Dihydropyrimidines and uses thereof

Morpholinone and morpholine derivatives and uses thereof

Dihydropyrimidines and uses thereof

JANSSEN PHARMACEUTICA NV

Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

Tetrahydro-indazole cannabinoid modulators

Phospholipase C inhibitors for use in treating inflammatory disorders

Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors

BRAIN CHRISTOPHER THOMAS

Pyrrolopyrimidine compounds and their uses

Pyrrolopyrimidine compounds as inhibitors of CDK4/6

Pyrrolopyrimidine compounds as inhibitors of CDK4/6

NOVARTIS AG

Pyrrolopyrimidine compounds and their uses

Pyridazinyl derivatives as SMO inhibitors

MERCK & CO INC

Alpha 1a adrenergic receptor antagonists

Alpha 1a adrenergic receptor antagonists

ASTELLAS ENG SMALL MOLECULES US INCORPORATED

HMOX1 inducers

CD38 inhibitors

BESONG GILBERT EBAI

Pyrrolopyrimidine compounds and their uses

HE FENG

Pyridazinyl derivatives as smo inhibitors

ORAPHARMA INC

Quaternary salt CCR2 antagonists

BESONG GILBERT

Pyrrolopyrimidine compounds and their uses

HOWARD STEVEN

Imidazole derivatives and their use as modulators of cyclin dependent kinases

LAGU BHARAT

Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes

BOCK MARK GARY

Pyrazoline derivatives and their use as selective androgen receptor modulators